← Back to Screener
Forian Inc. Common Stock (FORA)
Price$2.17
Value ScoreC
Growth ScoreA
Momentum ScoreB
Favorite Metrics
Price vs S&P 500 (26W)-11.62%
Price vs S&P 500 (4W)-4.43%
VGM Score71.48
Market Capitalization$64.01M
All Metrics
P/CF (Annual)22.18x
Book Value / Share (Quarterly)$0.96
P/TBV (Annual)2.29x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)2.61%
Cash Flow / Share (Quarterly)$0.09
Price vs S&P 500 (YTD)-7.36%
Gross Margin (TTM)53.21%
Net Profit Margin (TTM)-9.50%
EPS (TTM)$-0.09
10-Day Avg Trading Volume0.05M
EPS Excl Extra (TTM)$-0.09
Revenue Growth (5Y)123.71%
EPS (Annual)$-0.09
ROI (Annual)-9.65%
Gross Margin (Annual)53.21%
Net Profit Margin (5Y Avg)-44.15%
Cash / Share (Quarterly)$1.02
Revenue Growth QoQ (YoY)36.99%
ROA (Last FY)-6.51%
Revenue Growth TTM (YoY)50.13%
EBITD / Share (TTM)$-0.11
ROE (5Y Avg)-58.87%
Operating Margin (TTM)-12.44%
Cash Flow / Share (Annual)$0.09
P/B Ratio2.15x
P/B Ratio (Quarterly)2.21x
Net Income / Employee (Annual)$-57,500
EV / Revenue (TTM)1.69x
Net Interest Coverage (TTM)-116.95x
ROA (TTM)-6.30%
EV / EBITDA (TTM)9.94x
EPS Incl Extra (Annual)$-0.09
Current Ratio (Annual)2.97x
Quick Ratio (Quarterly)2.90x
3-Month Avg Trading Volume0.03M
52-Week Price Return16.67%
EV / Free Cash Flow (Annual)17.71x
Revenue / Employee (TTM)$605,100
Tangible BV / Share (Quarterly)$0.93
P/S Ratio (Annual)2.12x
Asset Turnover (Annual)0.69x
52-Week High$2.71
Operating Margin (5Y Avg)-64.01%
EPS Excl Extra (Annual)$-0.09
Tangible BV CAGR (5Y)-10.72%
26-Week Price Return0.00%
Quick Ratio (Annual)2.90x
13-Week Price Return4.33%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)2.97x
Enterprise Value$51.11M
Revenue / Share Growth (5Y)107.31%
Asset Turnover (TTM)0.66x
Book Value / Share Growth (5Y)12.56%
Revenue / Employee (Annual)$605,100
Inventory Turnover (Annual)54.53x
Pretax Margin (Annual)-8.75%
Cash / Share (Annual)$1.02
3-Month Return Std Dev10.30%
Gross Margin (5Y Avg)68.23%
Net Income / Employee (TTM)$-57,500
ROE (Last FY)-9.65%
Net Interest Coverage (Annual)-53.85x
EPS Basic Excl Extra (Annual)$-0.09
P/FCF (TTM)17.44x
Receivables Turnover (TTM)4.13x
EV / Free Cash Flow (TTM)17.71x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-0.09
Receivables Turnover (Annual)4.13x
ROI (TTM)-8.49%
P/S Ratio (TTM)2.12x
Pretax Margin (5Y Avg)-52.97%
Revenue / Share (Annual)$0.97
Tangible BV / Share (Annual)$0.93
Price vs S&P 500 (52W)-10.66%
Year-to-Date Return2.36%
5-Day Price Return0.93%
EPS Normalized (Annual)$-0.09
ROA (5Y Avg)-19.57%
Net Profit Margin (Annual)-9.50%
Month-to-Date Return0.46%
Cash Flow / Share (TTM)$-0.02
EBITD / Share (Annual)$-0.11
Operating Margin (Annual)-12.44%
LT Debt / Equity (Annual)0.00x
P/CF (TTM)22.18x
ROI (5Y Avg)-24.09%
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-0.09
P/TBV (Quarterly)2.29x
P/B Ratio (Annual)2.21x
Inventory Turnover (TTM)31.48x
Pretax Margin (TTM)-8.75%
Book Value / Share (Annual)$0.96
Price vs S&P 500 (13W)-3.80%
Beta0.49x
P/FCF (Annual)22.18x
Revenue / Share (TTM)$0.97
ROE (TTM)-9.43%
52-Week Low$1.64
vGradeC
gGradeA
mGradeB
vgmGradeB
Show chart for
Earnings Surprise History
Q1 26-0.13est. 0.02
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
2.17
2.17
2.17
2.17
Industry Peers — Computer Processing & Data(88)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
FORAForian Inc. Common Stock | C | A | B | $2.17 |
| ADPAutomatic Data Processing | D | C | B | $231.95 |
| WDAYWorkday, Inc. Class A Common Stock | D | B | C | $144.28 |
| RDDTReddit, Inc. | F | A | B | $173.45 |
| VRSKVerisk Analytics, Inc. Common Stock | D | D | C | $181.73 |
| TOSTToast, Inc. | D | A | D | $24.64 |
| APLDApplied Digital Corporation Common Stock | F | A | B | $39.62 |
| QBTSD-Wave Quantum Inc. | F | D | B | $23.85 |
| PEGAPegasystems Inc | D | D | D | $34.71 |
| HNGEHinge Health, Inc. | F | A | A | $63.62 |
| LIFLife360, Inc. Common Stock | D | B | C | $45.37 |
About
Forian Inc provides software and analytics platforms that enable healthcare, life sciences, and cannabis industry operators to optimize operational, clinical, and financial performance. The company leverages proprietary data and management capabilities to serve a diverse customer base across traditional and emerging markets.